- Home
- AMPS vs HUMA Comparison
AMPS vs HUMA Comparison
Compare AMPS & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPS
- HUMA
- Stock Information
- Founded
- AMPS 2009
- HUMA 2004
- Country
- AMPS United States
- HUMA United States
- Employees
- AMPS N/A
- HUMA N/A
- Industry
- AMPS Electric Utilities: Central
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- AMPS Utilities
- HUMA Health Care
- Exchange
- AMPS Nasdaq
- HUMA Nasdaq
- Market Cap
- AMPS 608.0M
- HUMA 584.8M
- IPO Year
- AMPS N/A
- HUMA N/A
- Fundamental
- Price
- AMPS $3.96
- HUMA $4.37
- Analyst Decision
- AMPS Strong Buy
- HUMA Strong Buy
- Analyst Count
- AMPS 9
- HUMA 7
- Target Price
- AMPS $5.38
- HUMA $13.43
- AVG Volume (30 Days)
- AMPS 1.1M
- HUMA 2.4M
- Earning Date
- AMPS 03-13-2025
- HUMA 03-21-2025
- Dividend Yield
- AMPS N/A
- HUMA N/A
- EPS Growth
- AMPS N/A
- HUMA N/A
- EPS
- AMPS 0.22
- HUMA N/A
- Revenue
- AMPS $185,992,000.00
- HUMA N/A
- Revenue This Year
- AMPS $30.74
- HUMA N/A
- Revenue Next Year
- AMPS $17.00
- HUMA $4,344.68
- P/E Ratio
- AMPS $17.86
- HUMA N/A
- Revenue Growth
- AMPS 25.90
- HUMA N/A
- 52 Week Low
- AMPS $2.71
- HUMA $2.81
- 52 Week High
- AMPS $7.28
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- AMPS 51.87
- HUMA 45.11
- Support Level
- AMPS $3.60
- HUMA $4.20
- Resistance Level
- AMPS $4.14
- HUMA $4.78
- Average True Range (ATR)
- AMPS 0.26
- HUMA 0.28
- MACD
- AMPS 0.02
- HUMA -0.02
- Stochastic Oscillator
- AMPS 70.53
- HUMA 42.17
About AMPS Altus Power Inc.
Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.